Rimona Margalit

Materials Science · Physical Sciences

32h-index11.5kcitations78works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Porphyrin and Phthalocyanine Chemistry(13), Nanoparticle-Based Drug Delivery(10), Lipid Membrane Structure and Behavior(9), Protein Interaction Studies and Fluorescence Analysis(9), Photosynthetic Processes and Mechanisms(8)

Publications78 total

Biomaterial-Based Particulate Drug Carriers
2020· 2 cited
Nanocarriers as an Emerging Platform for Cancer Therapy
2020· 176 cited
Bioadhesive Liposomes for Topical Treatment of Wounds
2020· 2 cited
Targeting and modulating infarct macrophages with hemin formulated in designed lipid-based particles improves cardiac remodeling and function
Journal of Controlled Release·2017· 42 cited
Treatment of respiratory damage in mice by aerosols of drug-encapsulating targeted lipid-based particles
Journal of Controlled Release·2016· 9 cited
MACROPHAGE-TARGETED LIPOSOMES WITH HEMIN IMPROVE CARDIAC REPAIR AND FUNCTION AFTER MYOCARDIAL INFARCTION
Journal of the American College of Cardiology·2015
Targeting Macrophage Subsets for Infarct Repair
Journal of Cardiovascular Pharmacology and Therapeutics·2014· 102 cited
Cancer cell sensitization and improved treatment efficacy by combined sodium butyrate and paclitaxel formulations is cancer-type specific
International Journal of Pharmaceutics·2013· 5 cited
Biomaterial-Based Particulate Drug Carriers
Pan Stanford Publishing eBooks·2012· 1 cited
Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response
Journal of Controlled Release·2011· 40 cited
Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
Biomaterials·2010· 140 cited
Novel steroid carbamates reverse multidrug-resistance in cancer therapy and show linkage among efficacy, loci of drug action and P-glycoprotein's cellular localization
European Journal of Pharmaceutical Sciences·2010· 14 cited
Novel fibrillar insulin formulations for oral administration: Formulation and in vivo studies in diabetic mice
Journal of Controlled Release·2010· 19 cited
Liposomal dexamethasone–diclofenac combinations for local osteoarthritis treatment
International Journal of Pharmaceutics·2009· 98 cited
Insights into modeling streptozotocin-induced diabetes in ICR mice
Lab Animal·2009· 41 cited
A color discriminating broad range cell staining technology for early detection of cell transformation
SHILAP Revista de lepidopterología·2009Open Access
A color discriminating broad range cell staining technology for early detection of cell transformation
Journal of Carcinogenesis·2009· 11 citedOpen Access
A novel Diclofenac-carrier for local treatment of osteoarthritis applying live-animal MRI
Journal of Controlled Release·2008· 38 cited
Three-dimensional characterization of drug-encapsulating particles using STEM detector in FEG-SEM
Micron·2008· 18 cited
Treatment of resistant human colon cancer xenografts by a fluoxetine–doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen
Cancer Letters·2008· 49 cited
page 1 of 4Next →

Frequent Co-authors

Dan Peer(10), Abel Schejter(6), Inbar Elron-Gross(6), Smadar Cohen(5), Yifat Glucksam(5), Noga Yerushalmi(4), Michal Rotenberg(4), Ilia Rivkin(3), Dina Melikhov(3), Yifat Glucksam-Galnoy(3), Jeffrey M. Karp(2), Omid C. Farokhzad(2), Róbert Langer(2), Tamar Ben-Mordechai(2), Jonathan Leor(2), Yaron Dekel(2), Ilana Schumacher(2), Mirit Argov(2), Aya Arad(2), Seungpyo Hong(1)